CytomX

CytomX is a clinical-stage biotechnology company developing targeted antibody therapeutics for cancer and other serious diseases. It generates revenue primarily through collaboration agreements with larger biopharmaceutical partners, which fund research, development, and milestone activities.

Relationship details are part of the Pro plan.